Caliber Imaging & Diagnostics (LCDX) Stock Price, News & Analysis

Company Overview

Caliber Imaging & Diagnostics, Inc. is a medical technology company focused on developing advanced imaging solutions that quantify trace elemental composition in human tissue. The firm’s core technology leverages spectral analysis methods adapted from mass spectrometry to deliver non-invasive, point-of-care measurements of bone health and related physiological parameters. By translating elemental imaging into a clinical setting, Caliber Imaging aims to enhance disease screening and monitoring for conditions such as osteoporosis and other metabolic bone disorders.

The company’s flagship product line features compact imaging devices designed to integrate into hospital and outpatient environments. These systems employ patented ionization and detection techniques to provide rapid, quantitative data on elements such as calcium and potassium within bone or soft tissue. Caliber Imaging’s platform offers clinicians an alternative to conventional radiographic densitometry by supplying elemental concentration maps that can improve diagnostic accuracy and support personalized treatment plans.

Originally established as Astrotech Analytical, Caliber Imaging & Diagnostics emerged following a strategic shift from space and environmental instrumentation to healthcare applications. The enterprise is headquartered in The Woodlands, Texas, and maintains research collaborations with academic and clinical institutions across North America. Caliber Imaging’s management team combines expertise in analytical chemistry, biomedical engineering, and regulatory affairs to guide the company through development, validation, and commercialization phases.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 2,788 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

LCDX Stock Analysis - Frequently Asked Questions

How do I buy shares of Caliber Imaging & Diagnostics?

Shares of LCDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Caliber Imaging & Diagnostics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Caliber Imaging & Diagnostics investors own include Etsy (ETSY), NIO (NIO), J C Penney (JCP), Tesla (TSLA), Costco Wholesale (COST), NVIDIA (NVDA) and Advanced Micro Devices (AMD).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:LCDX
• CIK: N/A
• Web: www.caliberid.com
• Phone: 585-239-9800
• Fax: N/A
• Employees: 28
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A